Home › Cancer (all types) › NCT06877884
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients
Who can join
Ages 18 to 120 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent Exclusion Criteria: Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative
About the study
This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.
Sponsor: N-Power Medicine · Participants: 20,000 · Started: Aug 1, 2022
Contact the study team
- Christer Svedman, MD · Phone: 833-467-6734
- Louise Polychronopoulos, PhD · Phone: 833-467-6734
Official record on ClinicalTrials.gov — NCT06877884
Locations in the U.S.
| California | Pacific Cancer Care, Monterey |
| Delaware | Bayhealth Cancer Center-Kent, Dover Bayhealth Cancer Center- Sussex, Milford |
| Illinois | Northwest Oncology & Hematology, Elk Grove Village |
| New Mexico | New Mexico Oncology Hematology Consultants, Albuquerque |
| Pennsylvania | Lankenau Medical Center, Paoli |
| Texas | Oncology Consultants, P.A., Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.